文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

现有近视多基因风险评分在新加坡多族裔成人中预测高度近视与近视性黄斑变性的潜力

The Potential of Current Polygenic Risk Scores to Predict High Myopia and Myopic Macular Degeneration in Multiethnic Singapore Adults.
PubMed 文献 · Ophthalmology · 2022-03-28

该基于人群的研究纳入新加坡眼科疾病流行病学研究中的5894名成人(2141名华人、1913名印度人、1840名马来人),评估源自欧洲最大近视全基因组关联研究的PRS预测高度近视(HM)和近视性黄斑变性(MMD)的能力。PRS预测HM的AUC为0.73,预测MMD的AUC为0.66;联合其他预测因素后分别升至0.84和0.79。PRS前5%个体发生HM的风险为其余95%个体的4.66倍,发生MMD的风险为3.43倍。

要点

  • PRS预测高度近视的AUC为0.73,联合年龄、性别、教育程度、族裔等预测因素后升至0.84。
  • PRS预测近视性黄斑变性的AUC为0.66,联合其他预测因素后升至0.79。
  • PRS前5%个体发生高度近视的风险为其余95%个体的4.66倍,发生近视性黄斑变性的风险为3.43倍。

核心结论

  • PRS是高度近视的良好预测指标,有助于识别高风险儿童以预防近视进展为高度近视。
  • PRS也能预测近视性黄斑变性,有助于识别需要更密切监测近视相关并发症的高风险近视成人。

研究设计与样本

  • 基于人群的研究,纳入新加坡眼科疾病流行病学研究中的5894名成人(2141名华人、1913名印度人、1840名马来人),平均年龄57.05±9.31岁。
  • PRS源自687289个HapMap3单核苷酸多态性(SNPs),来自迄今欧洲最大近视全基因组关联研究(n=260974)。
  • 评估PRS预测高度近视(361例,等效球镜<-5.00D)和近视性黄斑变性(240例,按国际近视性黄斑病变摄影分类与分级系统标准分级)相对于无近视对照(3774例,等效球镜>-0.5D)的能力。

主要发现

  • PRS预测高度近视的AUC为0.73(95%CI 0.70-0.75),预测近视性黄斑变性的AUC为0.66(95%CI 0.63-0.70)。
  • PRS联合其他预测因素(年龄、性别、教育程度、族裔;年龄×族裔、性别×族裔、教育程度×族裔交互项;以及20个基因型主成分)后,高度近视的AUC升至0.84(95%CI 0.82-0.86),近视性黄斑变性的AUC升至0.79(95%CI 0.76-0.82)。
  • PRS位于前5%的个体发生高度近视的风险为其余95%个体的4.66倍(95%CI 3.34-6.42),发生近视性黄斑变性的风险为其余95%个体的3.43倍(95%CI 2.27-5.05)。

临床怎么用

  • 作者认为PRS是高度近视的良好预测指标,有助于识别高风险儿童以预防近视进展为高度近视。
  • 作者认为PRS也能预测近视性黄斑变性,有助于识别需要更密切监测近视相关并发症的高风险近视成人。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the transancestry portability of current myopia polygenic risk scores (PRSs) to predict high myopia (HM) and myopic macular degeneration (MMD) in an Asian population. DESIGN: Population-based study. PARTICIPANTS: A total of 5894 adults (2141 Chinese, 1913 Indian, and 1840 Malay) from the Singapore Epidemiology of Eye Diseases study were included in the analysis. The mean ± standard deviation age was 57.05 ± 9.31 years. A total of 361 adults had a diagnosis of HM (spherical equivalent [SE] < -5.00 diopters [D]) from refraction measurements, 240 individuals had a diagnosis of MMD graded by the International Photographic Classification and Grading System for Myopic Maculopathy criteria from fundus photographs, and 3774 individuals were control participants without myopia (SE > -0.5 D). METHODS: The PRS, derived from 687 289 HapMap3 single nucleotide polymorphisms (SNPs) from the largest genome-wide association study of myopia in Europeans to date (n = 260 974), was assessed on its ability to predict patients with HM and MMD versus control participants. MAIN OUTCOME MEASURES: The primary outcomes were the area under the receiver operating characteristic curve (AUC) to predict HM and MMD. RESULTS: The PRS had an AUC of 0.73 (95% confidence interval [CI], 0.70-0.75) for HM and 0.66 (95% CI, 0.63-0.70) for MMD versus no myopia. The inclusion of the PRS with other predictors (age, sex, educational attainment [EA], and ancestry; age-by-ancestry, sex-by-ancestry, and EA-by-ancestry interactions; and 20 genotypic principal components) increased the AUC to 0.84 (95% CI, 0.82-0.86) for HM and 0.79 (95% CI, 0.76-0.82) for MMD. Individuals with a PRS in the top 5% showed up to a 4.66 (95% CI, 3.34-6.42) times higher risk of HM developing and up to a 3.43 (95% CI, 2.27-5.05) times higher risk of MMD developing compared with the remaining 95% of individuals. CONCLUSIONS: The PRS is a good predictor for HM and facilitates the identification of high-risk children to prevent myopia progression to HM. In addition, the PRS also predicts MMD and helps to identify high-risk adults with myopia who require closer monitoring for myopia-related complications.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Kassam I, Foo LL, Lanca C, et al. The Potential of Current Polygenic Risk Scores to Predict High Myopia and Myopic Macular Degeneration in Multiethnic Singapore Adults. Ophthalmology. 2022. PMID: 35358591. doi:10.1016/j.ophtha.2022.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。